He and other physicians allowed for the possibility that Trump was just offering hypothetical examples ... Post first reported at the time. One attendee remembers Trump bringing up the test ...

today announced that an abstract detailing a post-hoc analysis of the OPTIMIZE Study, an open-label clinical trial of XPHOZAH ® (tenapanor), was accepted as a poster presentation at the National ...

21 A two-sided significance level of 0.05 was used to test the null hypothesis of no ... Results are derived from post hoc analyses and should be viewed as exploratory only.